CalciMedica CALC
NASDAQ CALC
$0.57 -0.01 (-1.78%)
At close: Aug 21, 2026 · 4:00 PM EDT

CalciMedica (CALC) EBT Margin (2024 - 2026)

CalciMedica's (CALC) quarterly EBT Margin came in at 2784.04% in Q1 2026, down 5025.0% YoY from 56.53% in Q1 2025, and up 2.85% on a QoQ basis from 2706.9% in Q4 2025.

CalciMedica (CALC) EBT Margin (2024 - 2026) Analysis & Trends

CalciMedica (CALC) has 3 years of EBT Margin data on file, last reported at 2784.04% in Q1 2026.

  • Quarterly EBT Margin fell 5025.0% year-over-year to 2784.04% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 762.95% (down 110469.0% YoY) and the FY2025 annual result came in at 125.92%, down 291.0% from the prior year.
  • EBT Margin climbed to 2784.04% in Q1 2026, from 2706.9% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 6677.88% in Q2 2025 to a low of 2884.11% in Q4 2024.
  • A 3-year average of 1819.54% and a median of 1943.9% in 2024 frame the typical range for EBT Margin.
  • The widest YoY moves for EBT Margin: up 559101 bps in 2025, down 36585 bps in 2025.
  • Tracing CALC's EBT Margin over 3 years: stood at 2884.11% in 2024, then surged by 194 bps to 2706.9% in 2025, then gained by 3 bps to 2784.04% in 2026.
  • The last three EBT Margin figures came in at 2784.04% (Q1 2026), 2706.9% (Q4 2025), and 294.79% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 41.75%
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 35.61%
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 35.71%
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -528.97%
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 18.33%
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 13.77%
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -25.06%
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -2.67%
9 Royalty Pharma 27.27 Bn 26.43 Bn - 12.09%
10 CalciMedica 9.80 Mn -8.82 Mn - 1,600.37%

Historic Data

Download Data
DateValue
Jun 30, 2026 1,600.37%
Mar 31, 2026 2,784.04%
Dec 31, 2025 2,706.90%
Sep 30, 2025 294.79%
Jun 30, 2025 6,677.88%
Mar 31, 2025 2,834.29%
Dec 31, 2024 -2,884.11%
Sep 30, 2024 660.64%
Jun 30, 2024 1,943.90%
Mar 31, 2024 1,357.56%